Heatwurx Inc. (NASDAQ:PCSA – Get Free Report) was the target of a significant drop in short interest in the month of January. As of January 15th, there was short interest totaling 30,093 shares, a drop of 69.3% from the December 31st total of 98,000 shares. Get Heatwurx alerts:Get Our Latest Stock Report on PCSAHeatwurx Price PerformanceShares of Heatwurx stock remained flat at $3.14 during trading on Thursday. Heatwurx Company Profile(Get Free Report)Processa Pharmaceuticals, Inc, a clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment. Featured StoriesReceive News & Ratings for Heatwurx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heatwurx and related companies with MarketBeat.com's FREE daily email newsletter.